Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Yize Li
Assistant Professor
Assistant Professor
,
Life Sciences, School of (SOLS)
Assistant Professor
,
Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)
Assistant Professor
,
ASU-Banner Neurodegenerative Disease Research Center (NDRC)
h-index
1862
Citations
23
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2012
2023
Research activity per year
Overview
Fingerprint
Network
Scholarly Works
(38)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Yize Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
RNase L
100%
COVID-19
82%
Double-stranded RNA
39%
Virus
31%
Murine Coronavirus
29%
Oligoadenylate Synthetase
28%
Mouse Hepatitis Virus
27%
Coronavirus
26%
Ribonuclease
21%
Interferon-α (IFN-α)
21%
OASIS-3
20%
Epigenetic Regulation
20%
Histone
20%
Mimicry
20%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
17%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
16%
Viral
16%
Pregenomic RNA (pgRNA)
15%
Antibody Cocktail
15%
Coronavirus Infections
15%
ADAR1
14%
Molecular Mechanism
14%
Molecular Determinants
13%
Human Viruses
13%
Japanese Encephalitis Virus
13%
Innate Immune Pathways
13%
Coronavirus Replication
13%
SARS-CoV-2 Detection
13%
Antagonism
13%
Zika Virus
13%
Antiviral Activity
13%
2-5A
12%
Accessory Protein
11%
Innate Immune Response
11%
Phosphodiesterase
11%
Cell Death
10%
Oligoadenylate
10%
Evade
10%
Ribonuclease L
10%
Human Coronavirus (HCoV)
10%
Betacoronavirus
10%
NS1 Protein
8%
Liver
8%
Small Molecule Inhibitors
8%
Gene Expression
8%
Vaccinia Virus
8%
Innate Immunity
8%
NS1 Antigen
8%
Lethal Challenge
8%
NS1′
8%
Immunology and Microbiology
Ribonuclease L
78%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Virus
35%
Murine Hepatitis Virus
31%
Murine Coronavirus
30%
Coronavirinae
27%
interferon
21%
Immunity
18%
Middle East Respiratory Syndrome Coronavirus
16%
Viral Disease
15%
Lineages
15%
Macrophage
13%
Japanese Encephalitis Virus Group
13%
Japanese Encephalitis Virus
13%
Mouse Model
13%
Host Cell
12%
Coronavirus
12%
Virus Genome
11%
Innate Immune System
11%
Betacoronavirus
11%
Spike
10%
Gene Expression
10%
Coronaviridae
10%
Antiviral Activity
9%
Monoclonal Antibody
9%
COVID-19
9%
Cell Line
8%
Human Cell
8%
Viral Replication
8%
Myeloid
8%
Exon
8%
Vaccinia Vaccine
6%
Reverse Transcription Loop Mediated Isothermal Amplification
6%
Adenoviridae
6%
Cytotoxicity
6%
Torovirus
6%
RNA Editing
6%
Zika Virus
6%
Kupffer Cell
6%
Rousettus aegyptiacus
6%
Receptor Binding
6%
Stimulator of Interferon Genes
6%
Mouse Mutant
6%
Paramyxoviridae
6%
Serpin
6%
Histone
6%
Intravenous Immunoglobulin
6%
DNA Virus
6%
Carboxy Terminal Sequence
6%
Wild Type
6%
Biochemistry, Genetics and Molecular Biology
Ribonuclease L
68%
Double-Stranded RNA
16%
SARS Coronavirus
13%
Zika Virus
13%
RNA
13%
Cell Death
11%
Murine Coronavirus
9%
Coronavirinae
8%
Antiviral Activity
8%
Ribonuclease
8%
Small Molecule
8%
Epigenetics
7%
Enzyme
7%
Genomics
7%
Reverse Transcription
6%
Loop-Mediated Isothermal Amplification
6%
Cell Migration
6%
Chikungunya Virus
6%
Cytotoxicity
6%
Rousettus aegyptiacus
6%
Molecular Beacon
6%
Japanese Encephalitis Virus
6%
Japanese Encephalitis Virus Group
6%
2,5-Dimethoxy-4-iodoamphetamine
6%
Azacitidine
6%
Immunity
6%
Protein L
6%
Histone
6%
Dihydrolipoamide Dehydrogenase
6%
RNA Editing
6%
OAS1
6%
Virus Replication
6%
Flavivirus
5%
Interferon
5%
